Novartis Drug Exjade(R) Recommended by CHMP for EU Approval to Treat …

Published November 23, 2012

Novartis drug Exjade(R) recommended by CHMP for EU approval to treat …

Filed under: drug treatment news

Novartis International AG / Novartis drug Exjade® recommended by CHMP for EU approval to treat patients with non-transfusion-dependent thalassemia syndromes . Processed and transmitted by Thomson Reuters ONE. The issuer is solely responsible for …
Read more on Reuters

HRB to provide a 'timely picture' of drug situation

Filed under: drug treatment news

Over the past two years the National Documentation Centre on Drug Use (NDC), which launched its new website in 2009, has developed two dataset query systems — one for National Drug Treatment Reporting System (NDTRS) data and the other for …
Read more on Irish Medical Times

FDA Oks Glaxo's Thrombocytopenia Drug Promacta For New Indication – Update

Filed under: drug treatment news

(RTTNews.com) – The U.S. Food and Drug Administration on Monday approved GlaxoSmithKline plc's (GSK, GSK.L) Promacta as a new indication for treatment of thrombocytopenia -low blood platelet counts- in patients with chronic hepatitis C to allow them …
Read more on NASDAQ